p-Tau 212 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,443 results for “p-Tau 212”

Trials

View all 5252 →

Tau/P-Tau and Neurocognitive Outcomes in Children

20 participants · First posted Apr 30, 2018

A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

10 participants · First posted Sep 18, 2025

Tau PET/CT in Various Tau-Related Disease Patients

500 participants · First posted Nov 15, 2024

Drugs

View all 2759 →

P-Tau T217

11C-TAU-7

TAU-2023

Organizations

View all 140 →

Alpha Tau Medical

Israel

Sigma Tau I.f.r S.p.a.

SIGMA-TAU RESEARCH INC

United States

News

View all 4292 →

Quanterix Launches Novel P-Tau 205 and P-Tau 212 Assays to Advance Alzheimer's Research

Quanterix Launches First-to-Market p-Tau 205 and p-Tau 212 Assays for Alzheimer's Disease Research

FDA Grants Breakthrough Device Designation for Phospho-Tau 217 Blood Test for Alzheimer's Disease

Page 1 of 1245